Observational studyClinical toxicology (Philadelphia, Pa.)2023
Blood cannabinoid molar metabolite ratios are superior to blood THC as an indicator of recent cannabis smoking.
Observational study in Clinical toxicology (Philadelphia, Pa.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 11 citations in OpenAlex.
- Interpol review of forensic drug chemistry, 2022-2025.Forensic science international. Synergy · 2026Review
- Short-term residual effects of smoked cannabis on simulated driving performance.Psychopharmacology · 2026Article
- Exploring perceptions of cannabis use and employment implications among healthcare workers: a single-institution experience.Journal of cannabis research · 2026Article
- The detection of cannabinoids in breath after ingestion of cannabis-infused edibles.Journal of analytical toxicology · 2025Article
- Enhancing Methods for Research on Cannabis: A Workshop Report.Journal of cannabis research · 2025Review
- Cannabinoids detected in exhaled breath condensate after cannabis use.Journal of breath research · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 4 institutions in 1 country.
Funding
Abstract
introductionCannabis use is a growing concern in transportation and workplace incidents. Because Δ9-tetrahydrocannabinol is detectable after acute psychoactive effects have resolved, it has limitations as an indicator of recent usage or potential impairment.
methodsIn an observational study of driving and psychomotor performance, we measured whole blood Δ9-tetrahydrocannabinol plus its metabolites 11-hydroxy-Δ9-tetrahydrocannabinol and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol by liquid chromatography with tandem mass spectrometry at baseline and 30 min after starting a 15-minute interval of smoking cannabis in 24 occasional and 32 daily cannabis smokers. We calculated two blood cannabinoid molar metabolite ratios: 1) [Δ9-tetrahydrocannabinol] to [11-nor-9-carboxy-Δ9-tetrahydrocannabinol] and 2) ([Δ9-tetrahydrocannabinol] + [11-hydroxy-Δ9-tetrahydrocannabinol]) to [11-nor-9-carboxy-Δ9-tetrahydrocannabinol]. We compared these to blood [Δ9-tetrahydrocannabinol] alone as indicators of recent cannabis smoking.
resultsMedian Δ9-tetrahydrocannabinol concentrations increased from 0 (<limit of detection 0.2 µg/L) at baseline to 5.6 µg/L post-smoking in occasional users. Among daily users, these were 2.7 µg/L at baseline and 21.3 µg/L post-smoking. Median molar metabolite ratio 1 increased from 0 at baseline to 0.62 post-smoking in occasional users and from 0.08 at baseline to 0.44 post-smoking in daily users. The median molar metabolite ratio 2 increased from 0 to 0.76 in occasional users and from 0.12 to 0.54 among daily users. A molar metabolite ratio 1 cut-point of 0.18 yielded 98% specificity, 93% sensitivity, and 96% accuracy for identifying recent cannabis smoking. A molar metabolite ratio 2 cut-point of 0.27 yielded 98% specificity, 91% sensitivity, and 95% accuracy. The receiver operating characteristic curves for molar metabolite ratio 1 and molar metabolite ratio 2 were not statistically different (
conclusionsIn occasional and daily users, the blood cannabinoid molar metabolite ratios were superior to whole blood Δ9-tetrahydrocannabinol as indicators of recent cannabis smoking. We recommend measurement and reporting of Δ9-tetrahydrocannabinol, 11-hydroxy-Δ9-tetrahydrocannabinol, and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol, and their molar metabolite ratios in forensic and safety investigations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.